Several months ago, the weight loss drug Hydrocut was recalled due to links to liver damage. The FDA is now investigating another weight loss drug-Alli, made and sold by GlaxoSmithKline. In 2007, Alli was approved as the only non-prescription weight loss drug. The FDA is reconsidering that approval. In June, the FDA noted on its website that Orlistat, a form of Alli, is potentially harmful. There have been adverse event reports fir Alli which highlight possible liver problems, including hepatoxicology, linked to the product.

This does not mean that a solid link has been made. GlaxoSmithKline has stated that the incidents of liver damage could easily be explained by other factors. We will monitor this situation closely. As St. Louis injury attorneys, we represent individuals harmed by drug manufacturers. If you believe you have been harmed by Alli, please contact us for an immediate case evaluation at 1-800-517-0602.